# Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity

> **NCT05076227** · — · COMPLETED · sponsor: **Serge Thal** · enrollment: 1206 (actual)

## Conditions studied

- SARS-CoV2 Infection
- Immunisation Reaction
- Antibody Hypersensitivity
- Tolerance

## Interventions

- **DRUG:** IM injection of vaccination (mRNA vaccination)
- **DRUG:** IM injection of vaccination (vector based vaccination)

## Key facts

- **NCT ID:** NCT05076227
- **Lead sponsor:** Serge Thal
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-30
- **Primary completion:** 2022-03-27
- **Final completion:** 2022-03-27
- **Target enrollment:** 1206 (ACTUAL)
- **Last updated:** 2022-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05076227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05076227, "Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05076227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*